Stonebridge Financial Planning Group, LLC Moderna, Inc. Transaction History

Stonebridge Financial Planning Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	BUY	$118.38 - $210.04 $158,629 - $281,453	1,340 New	1,340 $0
Q2 2022 Aug 01, 2022	SELL	$117.13 - $176.59 $159,296 - $240,162	-1,360 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$126.46 - $235.05 $44,261 - $82,267	-350 Reduced 20.47%	1,360 $234,000
Q4 2021 Feb 02, 2022	SELL	$225.82 - $368.51 $11,291 - $18,425	-50 Reduced 2.84%	1,710 $273,000
Q3 2021 Nov 08, 2021	SELL	$221.9 - $484.47 $27,737 - $60,558	-125 Reduced 6.63%	1,760 $609,000
Q2 2021 Jul 28, 2021	BUY	$129.91 - $234.98 $2,598 - $4,699	20 Added 1.07%	1,885 $451,000
Q4 2020 Jan 27, 2021	BUY	$65.74 - $169.86 $13,147 - $33,972	200 Added 12.01%	1,865 $195,000
Q3 2020 Oct 26, 2020	BUY	$54.34 - $94.85 $68,740 - $119,985	1,265 Added 316.25%	1,665 $123,000
Q2 2020 Jul 24, 2020	BUY	$29.67 - $80.0 $2,967 - $8,000	100 Added 33.33%	400 $23,000
Q1 2020 Apr 15, 2020	BUY	$17.78 - $31.58 $5,334 - $9,474	300 New	300 $10,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Stonebridge Financial Planning Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Financial Planning Group, LLC with notifications on news.